SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 85 filers reported holding SEELOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,458 | +852.0% | 643,897 | +6083.0% | 0.00% | – |
| Q2 2023 | $12,443 | +72.9% | 10,414 | 0.0% | 0.00% | – |
| Q1 2023 | $7,195 | -44.7% | 10,414 | -44.9% | 0.00% | – |
| Q4 2022 | $13,000 | -35.0% | 18,914 | 0.0% | 0.00% | – |
| Q3 2022 | $20,000 | +53.8% | 18,914 | -1.3% | 0.00% | – |
| Q2 2022 | $13,000 | -18.8% | 19,164 | -2.5% | 0.00% | – |
| Q1 2022 | $16,000 | -61.9% | 19,664 | -23.5% | 0.00% | – |
| Q4 2021 | $42,000 | -32.3% | 25,714 | -0.4% | 0.00% | – |
| Q3 2021 | $62,000 | +10.7% | 25,815 | +21.1% | 0.00% | – |
| Q2 2021 | $56,000 | +60.0% | 21,325 | +203.3% | 0.00% | – |
| Q1 2021 | $35,000 | +94.4% | 7,032 | -39.7% | 0.00% | – |
| Q4 2020 | $18,000 | +63.6% | 11,671 | -0.3% | 0.00% | – |
| Q3 2020 | $11,000 | +266.7% | 11,704 | +282.0% | 0.00% | – |
| Q2 2020 | $3,000 | +200.0% | 3,064 | +48.4% | 0.00% | – |
| Q1 2020 | $1,000 | – | 2,064 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENDELL JEFFREY L | 4,933,024 | $4,133,000 | 0.30% |
| ACUTA CAPITAL PARTNERS, LLC | 295,896 | $248,000 | 0.12% |
| Connacht Asset Management LP | 231,551 | $194,000 | 0.10% |
| Uniplan Investment Counsel, Inc. | 1,564,605 | $1,310,000 | 0.08% |
| AdvisorShares Investments LLC | 358,796 | $301,000 | 0.05% |
| 1492 Capital Management LLC | 99,819 | $84,000 | 0.04% |
| Woodline Partners LP | 2,803,230 | $2,349,000 | 0.04% |
| Ikarian Capital, LLC | 257,883 | $215,000 | 0.03% |
| Sovereign Financial Group, Inc. | 75,000 | $63,000 | 0.02% |
| Aquatic Capital Management LLC | 6,400 | $5,000 | 0.01% |